Inventor · disambiguated record
Feroz Jameel
Also filed as: JAMEEL FEROZ
11 granted patents·3 pending applications·255 citations·filing 2000–2025
92Inventor score
Top patents by PatentIndex Score
14 records- 0197US6586573B1Albumin-free Factor VIII formulationsBAXTER INT·Filed 2000·Granted Jul 1, 2003·129 cites·47 claims
- 0296US7247707B2Albumin-free factor VIII formulationsUNIV CONNECTICUT·Filed 2006·Granted Jul 24, 2007·38 cites·2 claims
- 0395US11020459B2Factor VIII formulationsBAXALTA INC·Filed 2019·Granted Jun 1, 2021·9 cites·18 claims
- 0494US7087723B2Albumin-free factor VIII formulationsUNIV CONNECTICUT·Filed 2003·Granted Aug 8, 2006·48 cites·53 claims
- 0590US8372800B2Albumin-free factor VIII formulationsBAXTER INT·Filed 2011·Granted Feb 12, 2013·9 cites·39 claims
- 0689US8058226B2Albumin-free factor VIII formulationsBESMAN MARC·Filed 2007·Granted Nov 15, 2011·11 cites·47 claims
- 0787US9669076B2Albumin-free factor VIII formulationsBAXALTA INC·Filed 2016·Granted Jun 6, 2017·4 cites·13 claims
- 0884US8765665B2Albumin-free factor VIII formulationsBAXTER INT·Filed 2013·Granted Jul 1, 2014·4 cites·8 claims
- 0980US9352027B2Albumin-free factor VIII formulationsBAXTER INT·Filed 2014·Granted May 31, 2016·2 cites·10 claims
- 1071US12251365B2Pharmaceutical formulations for subcutaneous administrationABBVIE INC·Filed 2019·Granted Mar 18, 2025·1 cites·36 claims
- 1165US2010168018A1Factor viii formulationsBAXTER INT·Filed 2009·Application pending·0 cites
- 1258US2025325507A1Pharmaceutical formulations for subcutaneous administrationABBVIE INC·Filed 2025·Application pending·0 cites
- 1355US2025186382A1Pharmaceutical formulations for subcutaneous administrationABBVIE INC·Filed 2025·Application pending·0 cites
- 1454US10512674B2Factor VIII formulationsBAXALTA INC·Filed 2016·Granted Dec 24, 2019·0 cites·19 claims
Join the waitlist — get patent alerts
Get an alert when Feroz Jameel files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →